Donor Lymphocyte Infusion (DLI)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Donor Lymphocyte Infusion (DLI), covering 2014-01-08 to 2024-06-06. Get the full timeline:
Most recent: Clinical Trial Update: VMAC+DLI Treatment of Patients With Relapse of AML After Allo-HSCT [Phase 2]